Dengue Fever - MarketOpen Australia

December 11, 2024 Off

Island Pharmaceuticals (ASX:ILA) secures U.S. patent for dengue drug ISLA-101

Island Pharmaceuticals (ASX: ILA) has secured a U.S. patent for its lead antiviral drug ISLA-101, targeting dengue fever and bolstering its intellectual property portfolio until 2034.

November 27, 2024 Off

Island Pharmaceuticals (ASX:ILA) advances dengue fever battle with promising drug trial results

By MarketOpen

Island Pharmaceuticals (ASX:ILA) has achieved a major milestone with its lead drug ISLA-101, showing safety and anti-dengue activity in Phase 2a trials, paving the way for therapeutic testing.

Tag: Dengue Fever

Island Pharmaceuticals (ASX:ILA) secures U.S. patent for dengue drug ISLA-101

Island Pharmaceuticals (ASX:ILA) advances dengue fever battle with promising drug trial results

Contact info

Important links

Follow us

Island Pharmaceuticals (ASX:ILA) secures U.S. patent for dengue drug ISLA-101

Island Pharmaceuticals (ASX:ILA) advances dengue fever battle with promising drug trial results

Subscribe